Insider Cluster (3 insiders) ·Filed Aug 5, 2026

NRIX

Nurix Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 3 insiders, $0.5M total
Actionable Insight • Neutral

No material signal from this insider cluster. The small dollar amounts and pattern of option exercises followed by sales suggest routine liquidity management. Monitor for upcoming clinical catalysts or partnership announcements as the primary drivers for NRIX.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d ⚠ clustered
NRIX ▲ +6.01% at T+5d
NEUTRAL call ✓ call won +6.01% · α vs SPY +5.66% · entry $25.12 → $26.63
Next anchor: T+20d due 4w ago
Latest observation: T+17 -2.88% FF3 residual α
Entry anchored
Aug 4, 06:10 PM ET
via 1-min bar
T+1d
+0.40%
call +0.40% · α +0.56%
$25.22
settled 8w ago
T+5d
+6.01%
call +6.01% · α +5.66%
$26.63
settled 7w ago
T+20d
—
call — · α —
—
due 4w ago
T+60d
—
call — · α —
—
in 27d

Price Chart

Loading chart...

Executive Summary

Three C-suite insiders at Nurix Therapeutics (CSO, CLO, CFO) sold a total of $461K in open-market shares over a 7-day window, representing just 0.02% of the $2.4B market cap. The sales are trivial in size and appear liquidity-driven following option exercises, providing no material signal about the company's outlook.

Key Financial Metrics

Direction
selling
Total Value
$461.0K
Insiders
3

Key Facts

  • Total open-market insider sales: $461,000 across 3 C-suite executives (CSO, CLO, CFO)
  • Sales represent 0.02% of Nurix's $2.4B market cap — well below the 0.1% materiality threshold
  • Multiple derivative exercises (non-cash) preceded the sales, consistent with routine option exercise and tax-covering or diversification
  • Prior insider activity (30d) shows 6 sells totaling $665K, indicating ongoing but modest selling patterns

Financial Impact

Trivial insider sales totaling $461K, representing 0.02% of market cap.

insider sellingdilution from option exercises

Risk Factors

  • None from this filing — insider activity is immaterial in size and context

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NRIX-1785927676296
18 reports for NRIX
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +53.71%Jun 8, 2026
Filters
Rows
Reports for NRIX — sortable, filterable
TypeNow
Sep 2, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$25.32 $25.10▼ −0.87%▲ +0.28%$22.85 (−9.76%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.22 $27.19▲ +7.81%▲ +6.60%$22.85 (−9.40%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$25.12 $26.63▲ +6.01%▲ +5.66%$22.85 (−9.04%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.12 $26.63▲ +6.01%▲ +5.66%$22.85 (−9.04%)
Aug 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.69 $25.96▲ +5.14%▲ +5.24%$22.85 (−7.45%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$23.21 $25.53▲ +10.00%▲ +6.48%$22.85 (−1.55%)
Jul 9, 2026
12w ago
Press Release
BULLISH ★ 8/10
$23.06 $23.07▲ +0.04%▲ +0.60%$22.85 (−0.91%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$23.97 $24.69▲ +3.00%▲ +2.07%$22.85 (−4.67%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 4/10
$16.98 $17.12▲ +0.82%▲ +0.39%$22.85 (+34.57%)
Jun 8, 2026
16w ago
8-K
BULLISH ★ 8/10
$15.64 $17.04▲ +8.95%▲ +6.84%$22.85 (+46.10%)
Showing 10 of 18

US Market Status

Market Open — Closes in 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 5, 2026